VC  Sofinnova Ventures

http://www.sofinnova.com





     Office Locations:

1250 Prospect Street, Ocean Level - 4
La Jolla, CA 92037
Phone: 858-551-4880

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1974, Sofinnova Ventures invests venture capital in early-stage Life Science and Information Technology startup companies. The majority of the firm's investing is in the U.S., and about a tenth of its investments are made in Europe. Within the U.S., Soffinova's IT investing is heavily focused on the San Francisco Bay Area, while its Life Science investing covers San Diego, San Francisco, Seattle, and several cities on the East Coast. The firm focuses on promising seed-stage and first institutional round investments, but occasionally invests in intermediate- and later-stage startup companies. Soffinova's investments in technology companies range from $5 to $15 million, with an initial investment of $3 to $5 million; and most life science investments range from $15 to $30 million overall, with an initial investment of $5 to $15 million. In 2011, the firm raised $440M for Sofinnova Venture Partners VIII. In July of 2014 the firm announced the closing of Sofinnova Venture Partners IX, L.P. at the hard cap of $500 million, and in excess of the initial fund target of $425 million.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Alain Azan Founding Partner
    Anand Mehra Partner
    Brian Wilcove Advisor
    David Kabakoff Executive Partner
    Eric Buatois Advisor

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/01/2018


      VelosBio


      CA


      $58,000,000


      Series A


      08/07/2018


      Akouos


      MA


      $50,000,000


      Series A


      12/14/2017


      Pionyr Immunotherapeutics


      CA


      $62,000,000


      Series B


      11/27/2017


      Medeor Therapeutics


      CA


      $57,000,000


      Series B


     

    Portfolio companies include:


      Aclaris Therapeutics
        web link


      Akouos
        web link


      Alimera Sciences
        web link


      Alvine
        web link


      Amarin
        web link


      Amplyx Pharmaceuticals
        web link


      Anthera Pharmaceuticals
        web link


      Antiva Biosciences
        web link


      Ascenta Therapeutics
        web link


      aTyr Pharma
        web link


      BioClin Therapeutics
        web link


      Biovail
        web link


      Cataylst Biosciences
        web link


      Cebix
        web link


      Checkmate Pharmaceuticals
        web link


      Chiasma
        web link


      Civitas Therapeutics
        web link


      CrestaTech
        web link


      Durata Therapeutics
        web link


      Edge Therapeutics
        web link


      Entasis
        web link


      First Aid Shot Therapy (F.A.S.T.)
        web link


      Flexion Therapeutics
        web link


      Galera Therapeutics
        web link


      Guavus
        web link


      Histogenics
        web link


      Hyperion Therapeutics
        web link


      InteKrin Therapeutics
        web link


      Intellikine
        web link


      KaloBios
        web link


      Labrys Biologics


      Marinus Pharmaceuticals
        web link


      Medeor Therapeutics
        web link


      Mirna Therapeutics
        web link


      Natera
        web link


      NextCure


      NextWave Pharmaceuticals
        web link


      Ocera
        web link


      Orexigen
        web link


      Pionyr Immunotherapeutics
        web link


      Principia Biopharma
        web link


      SARcode Bioscience
        web link


      Sorbent Therapeutics
        web link


      Spark Therapeutics
        web link


      TESARO
        web link


      Trius Therapeutics
        web link


      VelosBio


      Versartis
        web link


     

    Recent News: